SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a ...
AM ESTMIAMI, Jan. 23, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage ...